| Financial Year |
March 31 2023 |
| Monetary Funds |
519,253,673.45 |
| Held-for-trading Financial Assets |
430,932,000.00 |
| Notes Receivable |
3,423,057.81 |
| Accounts Receivable |
281,829,702.66 |
| Advances to Suppliers |
6,417,362.11 |
| Other Receivables |
2,168,406.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
206,107,983.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
32,593.64 |
| Total Current Assets |
1,471,112,530.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
12,063,253.01 |
| Fixed Assetes |
105,903,701.88 |
| Under-construction Projects |
38,477,757.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,122,622.95 |
| R&D expenses |
-- |
| Goodwill |
96,640,193.47 |
| Long-Term Deferred and Prepaid Expenses |
11,310,404.60 |
| Deferred Income Tax Assets |
13,835,231.73 |
| Other Non-Current Assets |
1,181,361.47 |
| Sub-Total of Non-Current Assets |
441,630,760.44 |
| Total Assets |
1,912,743,291.32 |
| Short-Term Loans |
10,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
88,465,217.85 |
| Accounts Payable |
126,140,908.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
40,994,222.66 |
| Taxes Payable |
21,381,782.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
30,130,152.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,059,351.46 |
| Other Current Liabilities |
9,504,832.23 |
| Sub-Total of Current Liabilities |
390,224,559.08 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,187,126.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
30,849,787.97 |
| Total Liabilities |
421,074,347.05 |
| Paid-In Capital(Or Share Stock) |
249,648,907.00 |
| Capital Surplus |
392,635,258.88 |
| Surplus Reserve |
123,281,907.79 |
| LESS:Treasury Stock |
29,411,083.00 |
| Undistributed Profits |
727,212,493.45 |
| Minority Stockholder's Interest |
27,888,779.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,463,780,165.04 |
| Owner's Equity（Stockholder's Equity） |
1,491,668,944.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,912,743,291.32 |
